top of page

Publications 

Publication (latest first)

  1. Samarth Kansara, Agrata Singh, Abhishesh Kumar Badal, Reshma Rani, Prakash Baligar, Manoj Garg, Amit Kumar Pandey. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer. Semin Cancer Biol. 2023 Jun 25; 95:1-12. (IF-17)

  2. Jain CK, Srivastava P, Pandey AK, Singh N, Kumar RS. miRNA therapeutics in precision oncology: a natural premium to nurture. Explor Target Antitumor Ther. 2022;3(4):511- 532.

  3. Varun Rawat, Arkadi Vigalok, Anshu Kumar Sinha, Garima Sachdeva, Chandra Mohan Srivastava, Gyandshwar K. Rao*, Arun Kumar, Mandeep Singh, Komal Rathi, Ved Prakash Verma, Bhupender Yadav, Amit Kumar Pandey, Monika Vats. Synthesis of a Zirconium Complex of an N,O-type p-tert- Butylcalix[4]arene and Its Application in Some Multicomponent Reactions. ACS Omega. 2022, 7, 32, 28471- 28480. (IF: 4.1)

  4. Kovalenko TF, Yadav B, Anufrieva KS, Rubtsov YP, Zatsepin TS, Shcherbinina EY, Solyus EM, Staroverov DB, Larionova TD, Latyshev YA, Shakhparonov MI, Pandey AK, Pavlyukov MS. Functions of long non- coding RNA ROR in patient-derived glioblastoma cells. Biochimie. 2022 May 30; 200:131-139. (IF: 4.37)

  5. Anuradha Kirtonia, Amit Kumar Pandey, Balaji Ramachandran, Durga Prasad Mishra, David W Dawson, Gautam Sethi, Trivadi S Ganesan, H Phillip Koeffler, Manoj Garg. Overexpression of Laminin-5 Gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade. Cell Mol Life Sci. 2022 Jun 14;79(7):362 (IF: 9.2)

  6. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma, Ayushi Sharma, Samarth Kansara, Mehul Mahajan, Bhupender Yadav, Manoj Garg, Amit Kumar Pandey, 2021, 166240, ISSN 0925-4439, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, https://doi.org/10.1016/j.bbadis.2021.166240. IF: 5.187.

  7. A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma.Pandya G, Kirtonia A, Singh A, Goel A, Mohan CD, Rangappa KS, Pandey AK, Kapoor S, Tandon S, Sethi G, Garg M. 2021 May 26:S1044-579X(21)00157-7. Semin Cancer Biol. doi: 10.1016/j.semcancer.2021.05.027. IF : 15.70

  8. LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics.Bhupender Yadav, Sonali Pal, Yury Rubstov, Akul Goel, Manoj Garg, Marat Pavlyukov, Amit Kumar Pandey.
    Volume 24, 2021, Pages 728-742, ISSN 2162-2531, Molecular Therapy - Nucleic Acids. https://doi.org/10.1016/j.omtn.2021.03.018. IF : 8.886

  9. Anuradha Kirtonia, Kavita Gala, Stina George Fernandes, Gouri Pandya, Amit Kumar Pandey, Gautam Sethi, Ekta Khattar, Manoj Garg, Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics, Volume 68, 2021, Pages 258-278, ISSN 1044-579X, Seminars in Cancer Biology https://doi.org/10.1016/j.semcancer.2020.04.006. IF : 15.70

  10. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Gouri Pandya, Anuradha Kirtonia, Gautam Sethi, Amit Kumar Pandey, Manoj Garg. Volume 1874, Issue 2, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
    188423, ISSN 0304-419X, https://doi.org/10.1016/j.bbcan.2020.188423. IF : 10.68

  11. A brief overview of antitumoral actions of bruceine D. Sin ZW, Bhardwaj V, Pandey AK, Garg M., Explor Target Antitumor Ther. 2020;1: [Online First]

  12. Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer. S Kansara, V Pandey, PE Lobie, G Sethi, M Garg, AK Pandey, Cells, 9 (6), 1511, ISSN 2073-4409, IF : 6.600

  13. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. Anuradha Kirtonia, Gouri Pandya, Gautam Sethi, Amit K Pandey , Bhudev C Das & Manoj Garg . Journal of Molecular Medicine. (Accepted), ISSN 1432-1440. IF : 6.029

  14. Pal S, Garg M, Pandey AK. Deciphering the mounting complexity of the p53 regulatory network in correlation to lncRNAs in ovarian cancer. Cells.2020 Feb 25;9(3):527, ISSN 2073-4409. IF 6.600

  15. Rajagopalan D, Pandey AK, Xiuzhen MC, Lee KK, Hora S, Zhang Y, Chua BH, Kwok HS, Bhatia SS, Deng LW, Tenen DG, Kappei D, Jha S. TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter. PLoS Pathog. 2017 Oct 18; 13(10):e1006681. ISSN 1553-7374. IF-6.67

  16. Pandey V, Zhang M, Chong QY, You M, Raquib AR, Pandey AK, Liu DX, Liu L, Ma L, Jha S, Wu ZS, Zhu T, Lobie PE. Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells. Oncotarget. 2017 Aug 24; 8(44):77268-77291, ISSN 1949-2553. IF: 3.33

  17. Zhang Y, Subbaiah VK, Rajagopalan D, Tham CY, Abdullah LN, Toh TB, Gong M, Tan TZ, Jadhav SP, Pandey AK, Karnani N, Chow EKH, Thiery, JP, Jha S. TIP60 inhibits metastasis by ablating DNMT1-SNAIL2 driven epithelial- mesenchymal transition program. Journal of Molecular Cell Biology. 2016, ISSN 1759-4685. IF: 6.459

  18. Pandey AK, Zhang Y, Zhang S, Li Y, Tucker-Kellogg G, Yang H, Jha S. TIP60- miR-22 axis as a prognostic marker of breast cancer progression. Oncotarget. 2015 Dec 1; 6(38):41290-306, ISSN 1949-2553. IF: 3.33

  19. Tattikota SG, Rathjen T, McAnulty SJ, Wessels HH, Akerman I, van de Bunt M, Hausser J, Esguerra JL, Musahl A, Pandey AK, You X, Chen W, Herrera PL, Johnson PR, O'Carroll D, Eliasson L, Zavolan M, Gloyn AL, Ferrer J, Shalom- Feuerstein R, Aberdam D, Poy MN. Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metab. 2014 Jan 7; 19(1):122-34. ISSN  2381-1943. IF-27

  20. Tattikota SG*, Sury MD*, Rathjen T*, Wessels HH, Pandey AK, You X, Becker C, Chen W, Selbach M, Poy MN. Argonaute2 regulates the pancreatic β-cell secretome. Mol Cell Proteomics. 2013 May; 12(5):1214-25. (*-Shared authorship). ISSN 1535-9476. IF-6.564

  21. Vig S, Pandey AK, Verma G, Datta M. C/EBPα mediates the transcriptional suppression of human calreticulin gene expression by TNFα. Int J Biochem Cell Biol. 2012 Jan; 44(1):113-22. ISSN 1357-2725. IF: 4.24

  22. Kaur K, Pandey AK, Srivastava S, Srivastava AK, Datta M. Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver. Mol Biosyst. 2011 Dec; 7(12):3234-44. ISSN 1742-2051. IF-3.35

  23. Pandey AK, Verma G, Vig S, Srivastava S, Srivastava AK, Datta M. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol Cell Endocrinol. 2011 Jan 30; 332(1-2):125-33. ISSN 0303-7207. IF- 4.405

  24. Pandey AK, Munjal N, Datta M. Gene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favoured by TNFalpha in HepG2 cells. PLoS One. 2010 Feb 4; 5(2):e9063. ISSN 1932-6203. IF-5.13

  25. Pandey AK, Bhardwaj V, Datta M. Tumour necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells. FEBS J. 2009 Jul; 276(14):3757-69. ISSN 1742-4658. IF-4.39

  26. Pandey AK, Agarwal P, Kaur K, Datta M. MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem. 2009; 23(4-6):221-32. ISSN 1421-9778. IF- 4.64

​

Book Chapter

​

  1. Biomarker-based Targeted Therapeutics, Shainan Hora*, Amit Kumar Pandey* and Sudhakar Jha, *sharing first author, Intech 2018.

  2. Biomarkers as Putative Therapeutic Targets in Colorectal Cancer, Sonali pal, Manoj Garg, Amit Kumar Pandey*. (Chapter 8), 2020, (In Press).

​​

bottom of page